The researchers found that HSP70 exposed on the membrane of cancer cell-generated exosomes interacts with Toll-like receptor 2 (TLR2) on the surface of myeloid-derived suppressive cells (MDSC), thereby activating the latter and protecting cancer cells from immune recognition/attack. The gene discussed is HSPA1A; the disease is cancer.